• Investment World
• eWorld
• Brand Line
• Mentor
• Life
• Brand Quest
• The New Manager
• BL Club
• Smartbuy
• Books
• Gallery

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Foreign Exchange

• Rates
  
  

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources
• In Focus

Group Sites

• The Hindu
• The Hindu ePaper
• Business Line
• Business Line ePaper
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Our Bureau

Hyderabad, Jan. 25

In a public-private partnership, Apollo Hospitals has signed an agreement with Eisai Pharmaceuticals, Japan, and HelpAge India to provide better access to medicines to the underprivileged elderly patients suffering from dementia and depression.

Dementia is a neuro-psychiatric disorder in which memory and other cognitive functions like thought, comprehension, language, arithmetic, judgment and insight deteriorate progressively. The patient often experiences confusion, personality change, behaviour change, impaired judgement, difficulty finding words and so on. Alzheimer's is the most common cause of dementia.

The scope of the agreement is to explore collaboration followed by research between the companies for improving the rate of prevention, screening, diagnosis, treatment and support of dementia and depression among the elderly in India. The MoU was signed by Dr Prathap C. Reddy, Chairman, Apollo Hospitals Group, Mr Haruo Naito, President and CEO of Eisai Co, and Mr Amal Ganguli, President, HelpAge India.

More Stories on : Alliances & Joint Ventures | Health

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Copyright © 2011, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line